Peter Latham

home / authors / peter-latham

Articles

Costing Issues in the Production of Biopharmaceuticals

Costing Issues in the Production of Biopharmaceuticals

Peter Latham;Oliver Kaltenbrunner;John Curling;Howard Levine;Anurag S. Rathore

February 1st 2004

Operational planning and early cost analyses are key to generating optimal, robust, and economical commercial processes.

Latest Updated Articles

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Published: October 11th 2024 | Updated: March 3rd 2025

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com

Published: July 25th 2025 | Updated: July 31st 2025

Trade Policy Shifts: Compliance and Cost Strategies for Pharma

OleksKao - stock.adobe.com

Published: July 28th 2025 | Updated: July 31st 2025

AstraZeneca’s Imfinzi Advances in Gastric Cancer With FDA Priority Review

Chris Hagen, SCIEX

Published: July 21st 2025 | Updated: July 31st 2025

Video Interview With Chris Hagen, President of SCIEX

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.